Analytical Data
-
Gene name
SLC15A4
- Application
-
Alternative Names
PHT1; PTR4
-
Species
Human
-
Source
HEK293
-
Tag
N-StrepⅡ;C-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N697-1
-
Expression Region
M1-A577
-
Protein Length
Full Length of Isoform-1
-
Molecular Weight
67.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC15A4 is a member of the solute carrier family that encodes a proton-coupled oligopeptide transporter, playing a crucial role in the uptake of small peptides and certain drug molecules across cell membranes. Its relevance in various physiological and pathological processes has attracted considerable attention in recent years. Research has shown that SLC15A4 is involved in immune response regulation, particularly affecting antigen processing and presentation in dendritic cells. Dysregulation of this transporter has been implicated in autoimmune diseases and infections, highlighting its potential as a therapeutic target. The production of recombinant SLC15A4 protein has become a focus for researchers aiming to elucidate its structure-function relationship, study its transport mechanisms, and explore how it may influence drug absorption and metabolism. By generating and characterizing this recombinant protein, scientists can better understand its biological roles, which could lead to novel strategies for enhancing drug delivery and addressing related diseases. These studies contribute to a broader comprehension of the transporter’s implications in health and disease, paving the way for innovative treatments that leverage the transport capabilities of SLC15A4.
